Strategic Health Systems Pathology Biz Dev Exec

Quest Diagnostics; Clifton (NJ); On-site; USD 146,000 - 200,000; Full time

Benefits offered by this job

Day 1 Medical, dental & vision

401(k) with company match

Annual incentive plans

Education assistance

Employee stock purchase plan

Flexible Spending Accounts

Job summary

Quest Diagnostics is seeking a Health Systems Advanced Pathology Solutions Business Development Executive to drive revenue growth across major health systems and NCCN institutions. The role partners with oncology franchises to position AmeriPath, Dermpath Diagnostics, and related solutions, engaging C-suite and pathology leadership to negotiate high-value deals.

The field-based executive will travel 50–75% across the North and East regions, with remote work options depending on location,

Qualifications

• 7–10 years enterprise healthcare sales experience.
• 4+ years in Pathology/Oncology B2B environment.
• Experience negotiating complex enterprise contracts and SOWs.
• Willing to travel 50–75% as part of the role.

Responsibilities

• Target Major Health Systems & NCCN Accounts: identify, profile, and secure new, large-scale health system agreements.
• Position Quest’s Anatomic and Advanced Pathology portfolio including AmeriPath and Dermpath Diagnostics.
• Lead the development of sophisticated B2B proposals and Scopes of Work (SOW) for hospital leadership and executive committees.
• Identify and evaluate strategic partnerships and M&A opportunities.
• Engage with senior stakeholders to drive revenue growth and account expansion.

Skills

Healthcare B2B sales

Pathology/Oncology domain

Complex contracting

Education

Bachelor's degree in Life Sciences/Business

Master’s degree preferred

Job description

Quest Diagnostics is seeking a Health Systems Advanced Pathology Solutions Business Development Executive to drive revenue growth across major health systems and NCCN institutions. The role partners with oncology franchises to position AmeriPath, Dermpath Diagnostics, and related solutions, engaging C-suite and pathology leadership to negotiate high-value deals.

The field-based executive will travel 50–75% across the North and East regions, with remote work options depending on location,